21.8 C
New York
Monday, June 15, 2026

Tag: availability

Linx Security Launches Agentic Access Control to Deliver Real-Time Governance Over AI Agents

NEW YORK, June 9, 2026 /PRNewswire/ -- Linx Security, the AI-native identity security and governance platform, today announced the general availability of Linx Agentic...

Starvia Automotive Highlights Key Sourcing Checklist for Middle East Buyers Importing Chinese New Energy Vehicles

GUANGZHOU, China, June 9, 2026 /PRNewswire/ -- Starvia Automotive, a China-based automotive export service company, is highlighting the importance of a clear sourcing checklist...

BARRANCO GOLD MINING CORP. ENGAGES RIO MINERALS LTD. TO SUPPORT 2026 EXPLORATION PLANNING AT THE KING PROPERTY

CSE: BARFWB:314OTCQB: BRGMFVANCOUVER, BC, June 9, 2026 /CNW/ - Barranco Gold Mining Corp. ("Barranco" or the "Company") is pleased to announce that it has engaged Rio...

DNV Validates Fluence 99% Fleet Performance Availability for Large Energy Storage Projects

Comprehensive DNV analysis confirms strong operational performance, providing a verified benchmark for consistent uptime and revenue support
Comprehensive DNV analysis confirms strong operational performance, providing a verified benchmark for consistent uptime and revenue support

BARRANCO GOLD MINING CORP. ENGAGES RIO MINERALS LTD. TO SUPPORT 2026 EXPLORATION PLANNING AT THE KING PROPERTY

CSE: BARFWB:314OTCQB: BRGMFVANCOUVER, BC, June 9, 2026 /PRNewswire/ - Barranco Gold Mining Corp. ("Barranco" or the "Company") is pleased to announce that it has engaged Rio...

The Jackson Laboratory secures grant from The Michael J. Fox Foundation to advance Parkinson’s disease research through the JAX-NYSCF Collaborative

New human stem cell platform will expand access to standardized disease models, support Parkinson's disease research and therapeutic discovery efforts NEW YORK , June 9,...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

EASTERN PLATINUM LIMITED ANNOUNCES DISMISSAL OF CASES

VANCOUVER, BC, June 9, 2026 /CNW/ - Eastern Platinum Limited (TSX: ELR) (JSE: EPS) ("Eastplats" or the "Company") is pleased to announce that the...

American Fusion Inc. (OTC: AMFN) Provides Development and Testing Update for 5MW Pre-Production Texatron™ Fusion Engine™

American Fusion Provides Development and Testing Update for 5MW Pre-Production Texatron™ Fusion Engine™

U.S. GoldMining Provides Updates on the 2026 Exploration Program and District Infrastructure Catalysts at its 100% Owned Whistler Project, Alaska

ANCHORAGE, Alaska, June 9, 2026 /CNW/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to provide an update on the...

Scania launches modular protected cab and showcases hybrid defence capabilities at Eurosatory

At this year's Eurosatory, Scania will showcase defence solutions developed for demanding operations where protection, operational availability and sustained performance are essential.SÖDERTÄLJE, Sweden, June...

XRP Healthcare Reports More Than 74,000 Ecosystem Users as AI Healthcare Platform Delivers $1.2 Million in Prescription Savings

DUBAI, UAE, June 9, 2026 /PRNewswire/ -- XRP Healthcare, the first AI healthcare platform built on the XRP Ledger, today announced continued growth across...

Documentary “The Pl*nt” Arrives on Amazon Prime Video with a Landmark Final Interview from Dr. Raphael Mechoulam

Now streaming on Amazon Prime Video in Spain, 'The Pl*nt' combines Ferran Calbet's cinematic direction for HighVideo Films, in collaboration with Royal Queen Seeds. At its centre is what is believed to be Dr. Raphael Mechoulam's final filmed interview, offering a powerful exploration of cannabis science, history and stigma.

Exilby® Receives First European Marketing Authorization as VERTANICAL Prepares UK Submission for its First-in-Class Non-Opioid Treatment for Chronic Low Back Pain

GRÄFELFING, Germany, June 9, 2026 /PRNewswire/ -- VERTANICAL today announced that Exilby® (VER-01) has received marketing authorization in Germany for the treatment of chronic...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAvailability